GLP-1 Agonists Enter the Conversation on Psoriatic Disease
Dermatology Times reports GLP-1 agonists are being discussed for metabolic risk in psoriatic disease; the item names no trials, doses, or effect sizes.
Topic
Psoriatic Disease
Topic
Topic
Topic
Dermatology Times reports GLP-1 agonists are being discussed for metabolic risk in psoriatic disease; the item names no trials, doses, or effect sizes.